Brief: Lunit Highlights AI's Effect In Predicting Cancer Treatment Outcomes
Jan 18 (Reuters) - Lunit Inc 328130.KQ :
* LUNIT HIGHLIGHTS THE EFFECTIVENESS OF AI IN PREDICTING
CANCER
TREATMENT OUTCOMES - FINDINGS TO BE PRESENTED AT ASCO GI 2023
Source text for Eikon: ID:nPn8VQ8yYa
Further company coverage: 328130.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunit
See all newsBrief: Summit Therapeutics And Lunit Announce Agreement To Apply Ai-Powered Scope Io Platform For Tumor Microenvironment Analysis In Immuno-Oncology Development
Brief: Lunit Inc To Conduct Capital Increase Of 250 Billion Won
Brief: Lunit Announces Collaboration with Daiichi Sankyo on AI-Driven Biomarker Discovery
Brief: Lunit Inc - Awarded National Tender In France For Breast AI
Brief: Lunit Expands Partnership With Saudi Arabia's Largest Medical Group To Deploy Ai Chest X-Ray Solution